Celularity, Inc. (CELU)
0.6301
-0.05
(-7.99%)
USD |
NASDAQ |
Nov 13, 16:00
0.6336
0.00 (0.00%)
After-Hours: 19:59
Celularity Enterprise Value : 87.70M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 87.70M |
| November 12, 2026 | 89.30M |
| November 11, 2026 | 91.24M |
| November 10, 2026 | 90.07M |
| November 09, 2026 | 91.49M |
| November 06, 2026 | 91.51M |
| November 05, 2026 | 90.49M |
| November 04, 2026 | 92.93M |
| November 03, 2026 | 93.17M |
| November 02, 2026 | 92.75M |
| October 30, 2026 | 92.68M |
| October 29, 2026 | 94.12M |
| October 28, 2026 | 96.78M |
| October 27, 2026 | 92.39M |
| October 26, 2026 | 91.21M |
| October 23, 2026 | 97.88M |
| October 22, 2026 | 99.99M |
| October 21, 2026 | 99.12M |
| October 20, 2026 | 106.14M |
| October 19, 2026 | 103.22M |
| October 16, 2026 | 105.85M |
| October 15, 2026 | 108.19M |
| October 14, 2026 | 107.61M |
| October 13, 2026 | 110.83M |
| October 12, 2026 | 112.29M |
| Date | Value |
|---|---|
| October 09, 2026 | 114.93M |
| October 08, 2026 | 112.00M |
| October 07, 2026 | 112.29M |
| October 06, 2026 | 115.52M |
| October 05, 2026 | 119.32M |
| October 02, 2026 | 116.10M |
| October 01, 2026 | 109.66M |
| September 30, 2026 | 108.78M |
| September 29, 2026 | 109.37M |
| September 28, 2026 | 110.24M |
| September 25, 2026 | 109.66M |
| September 24, 2026 | 107.90M |
| September 23, 2026 | 102.92M |
| September 22, 2026 | 103.80M |
| September 21, 2026 | 105.56M |
| September 18, 2026 | 107.61M |
| September 17, 2026 | 106.44M |
| September 16, 2026 | 107.02M |
| September 15, 2026 | 105.56M |
| September 14, 2026 | 110.24M |
| September 11, 2026 | 110.54M |
| September 10, 2026 | 111.27M |
| September 09, 2026 | 111.42M |
| September 08, 2026 | 114.34M |
| September 04, 2026 | 118.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -39.96M |
| Exicure, Inc. | 5.167M |
| Century Therapeutics, Inc. | 219.34M |
| Absci Corp. | 1.286B |
| Cardio Diagnostics Holdings, Inc. | 1.890M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.546M |
| Revenue (Quarterly) | 5.432M |
| Total Expenses (Quarterly) | 4.886M |
| EPS Diluted (Quarterly) | 0.0186 |
| Gross Profit Margin (Quarterly) | 28.48% |
| Profit Margin (Quarterly) | 10.05% |
| Earnings Yield | -267.0% |
| Normalized Earnings Yield | -258.58 |